January 29, 2013
by admin
11 Comments
Healthcare provision, at least in the Western world, is in a permanent state of turmoil, as costs rise inexorably and politicians search for ways to cut spending without angering voters. But why do costs keep on rising so steeply? High … Continue reading
January 14, 2013
by admin
3 Comments
On January 11th, David Shaywitz (@DShaywitz) posted an excellent article on Forbes entitled “Are we the problem?”, in which he attributes many of difficulties in pharmaceutical R&D to the gap between how much we know about biology and how much … Continue reading
January 7, 2013
by admin
4 Comments
The pharmaceutical industry achieved 39 approvals in 2012 – the highest number for several years – triggering a much-needed wave of optimism. But sadly approval is not a guarantee of either patient benefit or commercial success. So DrugBaron looked a … Continue reading